A Single Pathogen Inactivation System
For Both Platelets & Plasma
The INTERCEPT Blood System allows you to efficiently control the safety of your platelets and plasma by implementing pathogen inactivation technology right in your own blood center or hospital blood bank.
Efficient and flexible processing
Same illumination device, same process and same active compound; designed for high throughput processing (>20 units/hour/instrument) of platelets and plasma from whole blood and apheresis collections.
Learn more: mechanism of action, platelet and plasma range requirements, processing steps, illuminator and disposables or process video.
Broad range of inactivation
Proven inactivation >5 logs for a broad range of viruses (enveloped and non-enveloped), bacteria and protozoa, both intracellular and extracellular, as well as leukocytes.
Meets pharmaceutical registration standards
Extensive preclinical characterization, Phase I through III clinical trials and European regulatory submissions including full Drug Dossier to support safety and efficacy of amotosalen.
Unique process control
Designed to deliver consistent treatment within specified ranges; microprocessor-controlled illumination device and design of processing set ensure reproducibility; IDMS software provides traceability.
Use of the INTERCEPT Blood System in the United States is limited by Federal law to investigational use. If you are a resident of the U.S., please click here.
The information on this site is not country-specific, and may contain information that is outside the approved indications for the country in which you are located. The INTERCEPT Blood System is CE marked for use with platelets and plasma.
Website design by NetPilot Web Solutions